Strata Critical Medical, Inc. (SRTA) — Strategic Asset Allocation Index
Strata Critical Medical, Inc. (SRTA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $- plus long-term investments of $390.00K) total $390.00K, measured against net assets of $274.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SRTA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Strata Critical Medical, Inc. Strategic Asset Allocation Index (2021–2022)
This chart shows how Strata Critical Medical, Inc.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $390.00K against net assets of $274.49 Million USD. See SRTA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Strata Critical Medical, Inc. (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Strata Critical Medical, Inc. from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Strata Critical Medical, Inc. market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $390.00K | $- | $390.00K | $274.49 Million | ▲ +0.1 pp |
| 2021 | 0.1% | $200.00K | $- | $200.00K | $291.37 Million | — |